The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b study of ARN-509 with abiraterone acetate (AA) and prednisone (P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
 
Edwin M. Posadas
No Relationships to Disclose
 
Kim N. Chi
Honoraria - Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi; Takeda
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Exelixis (Inst); Janssen (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst)
 
Ronald De Wit
No Relationships to Disclose
 
Maja J. De Jonge
No Relationships to Disclose
 
Gerhardt Attard
Employment - Institute of Cancer Research
Honoraria - Astellas Pharma; Janssen; Roche Pharma AG; Sanofi; Takeda; Ventana Medical Systems
Consulting or Advisory Role - Abbott Laboratories; Astellas Pharma; Janssen-Cilag; Medivation; Millennium; Novartis; Roche Pharma AG; Ventana Medical Systems; Veridex
Research Funding - AstraZeneca; Janssen
Other Relationship - Abbott Laboratories; Astellas Pharma; Janssen; Medivation; Roche Pharma AG; Ventana Medical Systems
 
Terence W. Friedlander
Speakers' Bureau - Astellas Pharma; Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma
 
Margaret K. Yu
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Peter Hellemans
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Caly Chien
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Charlene Connelly Abrams
Employment - Janssen Research & Development
 
Martha Gonzalez
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Geralyn Carol Trudel
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Vijay Chauhan
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - Janssen Research & Development
 
Juhui James Jiao
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - Janssen Research & Development
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Novartis; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bavarian Nordic; Janssen Oncology; Millennium; Novartis; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)